Neurogene Inc. (NGNE) Insider Trading -- Recent Executive & Director Transactions

4 insiders reported 27 Form 4 transactions for Neurogene Inc. (NGNE) over the past 18 months (most recent 2026-07-07). Recent activity: Cvijic Christine Mikail (President and CFO) Sell 4,200 shares, Cvijic Christine Mikail (President and CFO) Sell 600 shares, Cvijic Christine Mikail (President and CFO) Sell 739 shares, Cvijic Christine Mikail (President and CFO) Sell 2,531 shares, Cvijic Christine Mikail (President and CFO) Sell 1,530 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-07Cvijic Christine MikailPresident and CFOSell4,200$151,763
2026-07-07Cvijic Christine MikailPresident and CFOSell600$21,613
2026-07-02Cvijic Christine MikailPresident and CFOSell739$25,170
2026-07-02Cvijic Christine MikailPresident and CFOSell2,531$87,519
2026-07-02Cvijic Christine MikailPresident and CFOSell1,530$53,897
2026-05-08Cvijic Christine MikailPresident and CFOSell4,800$144,351
2026-05-08Cvijic Christine MikailPresident and CFOSell4,800$155,692
2026-03-30Jordan JulieChief Medical OfficerSell828$18,125
2026-03-30Cvijic Christine MikailPresident and CFOSell2,558$55,304
2026-03-30McMinn RachelChief Executive OfficerSell3,352$73,979
2026-03-17Cvijic Christine MikailPresident and CFOSell263$5,791
2026-03-17Cvijic Christine MikailPresident and CFOSell1,395$29,644
2026-03-17Cvijic Christine MikailPresident and CFOSell2,387$48,743
2026-03-17Cobb StuartChief Scientific OfficerSell3,991$81,456
2026-03-17Cobb StuartChief Scientific OfficerSell2,658$56,722
2026-03-17Cobb StuartChief Scientific OfficerSell148$3,268
2026-03-03Cvijic Christine MikailPresident and CFOSell4,800$120,528
2026-02-24Cobb StuartChief Scientific OfficerBuy16,500$0
2026-02-24Cvijic Christine MikailPresident and CFOBuy22,000$0
2026-02-24McMinn RachelChief Executive OfficerBuy25,900$0
2026-02-24Jordan JulieChief Medical OfficerBuy4,900$0
2025-05-15Cobb StuartChief Scientific OfficerSell6,797$102,975
2025-03-28Cvijic Christine MikailPresident and CFOBuy20,300$0
2025-03-28McMinn RachelChief Executive OfficerBuy23,900$0
2025-03-28Jordan JulieChief Medical OfficerBuy8,400$0

Source: SEC Form 4 filings · as of 2026-07-07